2-206662942-A-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001093730.1(DYTN):ā€‹c.1594T>Cā€‹(p.Ser532Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,613,522 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: š‘“ 0.0000066 ( 0 hom., cov: 30)
Exomes š‘“: 6.8e-7 ( 0 hom. )

Consequence

DYTN
NM_001093730.1 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.291
Variant links:
Genes affected
DYTN (HGNC:23279): (dystrotelin) This gene belongs to the dystrophin superfamily, which is characterized by the presence of four EF-hand motifs and a ZZ-domain. It is a likely ortholog of the Drosophila 'discontinuous actin hexagon' gene. It is noteworthy that the coding region of this gene lacks two coding exons that are found in the mouse ortholog. Human transcripts including these two exons are subject to nonsense-mediated transcript decay (NMD). On the other hand, transcripts skipping the two coding exons are expressed at very low levels. While this gene maintains an intact CDS, it may be an evolving pseudogene. However, after a discussion about this gene within the RefSeq group, as well as in the consensus coding sequence (CCDS) collaboration, it was decided to keep it as a protein-coding gene in the RefSeq, Ensembl-GENCODE and the CCDS sets. [provided by RefSeq, Jul 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.045310825).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DYTNNM_001093730.1 linkuse as main transcriptc.1594T>C p.Ser532Pro missense_variant 11/12 ENST00000452335.2 NP_001087199.1 A2CJ06

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DYTNENST00000452335.2 linkuse as main transcriptc.1594T>C p.Ser532Pro missense_variant 11/121 NM_001093730.1 ENSP00000396593.2 A2CJ06
DYTNENST00000674258.1 linkuse as main transcriptn.2145T>C non_coding_transcript_exon_variant 14/15

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
151932
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461590
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
727070
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000658
AC:
1
AN:
151932
Hom.:
0
Cov.:
30
AF XY:
0.0000135
AC XY:
1
AN XY:
74216
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 27, 2024The c.1594T>C (p.S532P) alteration is located in exon 11 (coding exon 11) of the DYTN gene. This alteration results from a T to C substitution at nucleotide position 1594, causing the serine (S) at amino acid position 532 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
18
DANN
Benign
0.93
DEOGEN2
Benign
0.0068
T
Eigen
Benign
-0.81
Eigen_PC
Benign
-0.74
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.33
T
M_CAP
Benign
0.0054
T
MetaRNN
Benign
0.045
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
1.3
L
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-1.2
N
REVEL
Benign
0.026
Sift
Benign
0.19
T
Sift4G
Benign
0.16
T
Polyphen
0.028
B
Vest4
0.095
MutPred
0.21
Loss of helix (P = 0.0167);
MVP
0.061
MPC
0.032
ClinPred
0.068
T
GERP RS
1.2
Varity_R
0.11
gMVP
0.21

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1699528968; hg19: chr2-207527666; API